Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials. - Flórez-Grau G; Zubizarreta I; Cabezón R; Villoslada P; Benitez-Ribas D (Frontiers in immunology, 2018)